Press release
Apixaban Market to Perceive Highest Growth of USD 2,908.17 Million by Forecast 2030
Apixaban Market
The market is projected to observe major growth during the forecast period. Apixaban is generally indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The recommended dose of Eliquis is 5mg orally twice a day. Apixaban is available in the market in both capsule and tablet form. The development of advanced anticoagulants increases the demand and provides numerous options to patients and healthcare professionals.
Data Bridge Market Research analyses a growth rate in the global apixaban market in the forecast period 2023-2030. The expected CAGR of the global apixaban market tends to be around 5.70% in the mentioned forecast period. The market was valued at USD 1,765.8 million in 2022 and would grow to USD 2,908.17 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Opportunities
Increasing R&D developments
There has been an increasing development in the research end front, creating many opportunities for market growth. For instance, the ARISTOTLE trial showed that apixaban is superior to warfarin in decreasing stroke and systemic embolism in patients with atrial fibrillation. Pfizer collaborated with Bristol-Myers Squibb to develop and commercialize apixaban; the alliance strengthens both companies to expand potential in cardiovascular drug development and commercialization.
Presence of cost-effective alternative
The apixaban is the third non-vitamin K antagonist oral anticoagulant used for clinical practice. The regular dose of apixaban is highly effective in decreasing thromboembolic events compared to warfarin. In December 2019, the US FDA approved the first generics of apixaban tablets, and FDA's generic drug program enables access to cost-effective and high-quality drugs
Segmentation:
The global apixaban market is segmented on the basis of dosage form, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Dosage Form
Capsule
Tablets
End-Users
Hospitals
Homecare
Specialty Clinics
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacies
Others
What benefits does DBM research study is going to provide?
Latest industry influencing trends and development scenario
Open up New Markets
To Seize powerful market opportunities
Key decision in planning and to further expand market share
Identify Key Business Segments, Market proposition & Gap Analysis
Assisting in allocating marketing investments
Key Market Players:
Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France), Pfizer Inc. (US.)
GSK plc (UK.)
Novartis AG (Switzerland)
AstraZeneca (UK.)
Johnson & Johnson Private Limited (US.)
Sun Pharmaceutical Industries Ltd. (India)
Merck & Co., Inc. (US.)
Bristol-Myers Squibb Company (US.)
Lilly (US.)
Amgen Inc. (US.)
Eisai Co., Ltd (Japan)
Aspen Holdings (South Africa)
Fresenius Kabi AG (Germany)
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. (China)
Key Questions Answered
What impact does COVID-19 have made on Global Apixaban Market Growth & Sizing?
Who are the Leading key players and what are their Key Business plans in the Global Apixaban Market?
What are the key concerns of the five forces analysis of the Global Apixaban Market?
What are different prospects and threats faced by the dealers in the Global Apixaban Market?
What are the strengths and weaknesses of the key vendors?
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-apixaban-market
More Reports:
https://sagark18dbmr.blogspot.com/2023/05/electron-beam-linear-accelerator-market.html
https://sagark18dbmr.blogspot.com/2023/05/hay-wells-syndrome-treatment-market.html
https://sagark18dbmr.blogspot.com/2023/05/alstorm-syndrome-treatment-market-size.html
https://sagark18dbmr.blogspot.com/2023/05/molecularly-long-chain-fatty-acid.html
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email - corporatesales@databridgemarketresearch.com
About Us:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Apixaban Market to Perceive Highest Growth of USD 2,908.17 Million by Forecast 2030 here
News-ID: 3072049 • Views: …
More Releases from DBMR
Feed Pigments Market - Industry Trends and Forecast
Global Feed Pigments Market, By Type (Carotenoids, Curcumin, Caramel, Spirulina and Others), Carotenoids Source (Natural and Synthetic), Livestock (Swine, Poultry, Ruminants, Aquatic Animals and Others) - Industry Trends and Forecast to 2029.
Feed Pigments Market Analysis and Size
Feed pigments are used to enhance the colour of products such as eggs, meat, and milk. The key drivers for this market are rising meat production demand, rising disposable incomes, a shift toward pellet…
Automatic Brewing Equipment Market - Industry Trends and Forecast
Global Automatic Brewing Equipment Market, By Brewery Type (Macrobrewery, Craft Brewery), Equipment Type (Macrobrewery Equipment, Craft Brewery Equipment), Material Type (Brass, CopperAluminumStainless steel, Mild steel) - Industry Trends and Forecast to 2029.
Automatic Brewing Equipment Market Analysis and Size
Beers provide antioxidants and are a low-calorie alternative to other drinks. Along with being appropriately rich in vitamin B, vitamin B3, and vitamin B6, it also gives our bodies with vital fibre content.…
Digestive Health Food and Drinks Market - Industry Trends and Forecast
Data Bridge Market Research analyses that the global digestive health food and drinks market to account USD 63.43 billion by 2029 growing at a CAGR of 7.85% in the forecast period of 2022-2029.
Digestive health drinks are products that help to counteract the effects of an overburdened digestive tract. Drinks, when consumed properly, can aid in the prevention of a variety of small and large intestine health problems. There are…
Activin A Market Size, Share, Growth, Trends and Forecast
Activin A market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.50% in the above mentioned forecast period.
Activin A is a member of the TGF-beta super family and shows structural similarities with TGF-beta 1. Activins are the disulphide linked dimeric proteins that causes stimulation of pituitary follicle stimulating hormone…
More Releases for Apixaban
Global Apixaban Prices Q2 2025: Chart, Analysis & Forecast
North America Apixaban Prices Movement Q2:
Apixaban Prices in USA:
In Q2 2025, apixaban prices in the USA reached 44,617 USD/MT in June. Prices rose steadily, supported by consistent demand for cardiovascular therapies, higher API production and compliance costs, and stable healthcare utilization. Generics moderated volatility, yet firm supply chains and sustained consumption maintained a controlled, input cost-driven price increase.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample
Note: The analysis can be tailored to align…
Apixaban Market Analysis Current Landscape and Future Outlook
The Apixaban market is expected to grow at a CAGR of 6.2% between 2025 and 2035, driven by the rising prevalence of cardiovascular diseases, increasing awareness of stroke prevention, and the growing preference for direct oral anticoagulants (DOACs) over traditional blood thinners.
Apixaban Market Overview
Apixaban is a factor Xa inhibitor that is widely used for the prevention and treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and stroke…
Key Trend Reshaping the Apixaban Market in 2025: Rise Of Generic Apixaban Expand …
What market dynamics are playing a key role in accelerating the growth of the apixaban market?
The increase in cases of cardiovascular disease is anticipated to boost the expansion of the apixaban market. The term cardiovascular disease covers a variety of conditions that impact the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. The escalation in cardiovascular diseases can be attributed to inactive lifestyles, poor nutrition,…
Primary Catalyst Driving Apixaban Market Evolution in 2025: Impact Of Cardiovasc …
What Is the Future Outlook for the Apixaban Market's Size and Growth Rate?
In the past few years, there has been significant growth in the apixaban market size. It is projected to ascend from $2.92 billion in 2024 to $3.19 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historic period is due to factors such as the rising case of atrial fibrillation,…
Apixaban Market: Growth Dynamics, Trends, and Opportunities
Apixaban, an oral anticoagulant primarily used to prevent and treat blood clots, has become a cornerstone in modern medical practice. As an integral part of managing cardiovascular and thromboembolic disorders, its role in healthcare continues to expand. This article delves into the Apixaban market, covering its size, evolution, trends, growth drivers, and the increasing demand propelling its trajectory.
Market Size
Data Bridge Market Research analyses a growth rate in the global apixaban…
Apixaban Market Overview, Trends And Forecast 2024-2033
The new report published by The Business Research Company, titled ""Apixaban Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the apixaban market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to…
